Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0161 | 0.6427 | 1 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0242 | 1 | 1 |
Giardia lamblia | Ubiquitin carboxyl-terminal hydrolase 4 | 0.0161 | 0.6427 | 0.5 |
Echinococcus multilocularis | Peptidase C19, ubiquitin carboxyl terminal hydrolase 2 | 0.0161 | 0.6427 | 1 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0107 | 0.405 | 0.5677 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0107 | 0.405 | 0.5677 |
Trypanosoma brucei | ubiquitin carboxyl-terminal hydrolase, putative | 0.0161 | 0.6427 | 1 |
Entamoeba histolytica | ubiquitin carboxyl-terminal hydrolase domain containing protein | 0.0161 | 0.6427 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0071 | 0.2478 | 0.3856 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0036 | 0.0928 | 0.5 |
Trypanosoma cruzi | ubiquitin carboxyl-terminal hydrolase, putative | 0.0161 | 0.6427 | 1 |
Brugia malayi | Inositol-1 | 0.0036 | 0.0928 | 0.0264 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.405 | 0.6302 |
Echinococcus granulosus | Peptidase C19 ubiquitin carboxyl terminal hydrolase 2 | 0.0161 | 0.6427 | 1 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0161 | 0.6427 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0161 | 0.6427 | 1 |
Echinococcus multilocularis | ubiquitin carboxyl terminal hydrolase 8 | 0.0161 | 0.6427 | 1 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0032 | 0.0761 | 0.5 |
Loa Loa (eye worm) | inositol-1 | 0.0036 | 0.0928 | 0.0764 |
Schistosoma mansoni | inositol monophosphatase | 0.0036 | 0.0928 | 0.1445 |
Brugia malayi | Ubiquitin carboxyl-terminal hydrolase family protein | 0.0161 | 0.6427 | 0.6165 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0928 | 0.0429 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0107 | 0.405 | 0.5677 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.405 | 0.6302 |
Brugia malayi | Melibiase family protein | 0.0071 | 0.2478 | 0.1928 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.6427 | 0.6362 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0928 | 0.0429 |
Schistosoma mansoni | inositol monophosphatase | 0.0036 | 0.0928 | 0.1445 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0928 | 0.0429 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0071 | 0.2478 | 0.2819 |
Echinococcus granulosus | ubiquitin specific protease 41 | 0.0161 | 0.6427 | 1 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0036 | 0.0928 | 0.0429 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0031 | 0.0682 | 0.0514 |
Leishmania major | ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative | 0.0161 | 0.6427 | 1 |
Echinococcus multilocularis | ubiquitin specific protease 41 | 0.0161 | 0.6427 | 1 |
Schistosoma mansoni | ubiquitin-specific peptidase 8 (C19 family) | 0.0161 | 0.6427 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.405 | 0.6302 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0031 | 0.0682 | 0.0514 |
Trichomonas vaginalis | Clan CA, family C19, ubiquitin hydrolase-like cysteine peptidase | 0.0161 | 0.6427 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0107 | 0.405 | 0.6302 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2478 | 0.2342 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0036 | 0.0928 | 0.2292 |
Echinococcus granulosus | ubiquitin carboxyl terminal hydrolase 8 | 0.0161 | 0.6427 | 1 |
Toxoplasma gondii | melibiase subfamily protein | 0.0107 | 0.405 | 1 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0032 | 0.0761 | 0.5 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0031 | 0.0682 | 0.0514 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0036 | 0.0928 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0071 | 0.2478 | 0.3856 |
Schistosoma mansoni | ubiquitin-specific peptidase 2 (C19 family) | 0.0161 | 0.6427 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.5623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.